Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

NCT06049147 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Pharmacokinetic

Interventions

DRUG: MBF-015 4 mg oral capsule
DRUG: MBF-015 16 mg oral capsule
DRUG: Placebo

Sponsor

Medibiofarma S.L.